GlaxoSmithKline (GSK) agreed to acquire a clinical-stage drug from Chimagen Biosciences, a privately held Chinese biotechnology company. CMG1A46 is a dual CD19 and CD20...

Merck KGaA has announced a €70 million expansion of its ADC manufacturing capacity at its Centre of Excellence for Bioconjugation in St. Louis, Missouri, USA. The...

US drugmaker AbbVie has signed an agreement to acquire biotechnology company Aliada Therapeutics, which develops therapies for central nervous system (CNS) diseases using...

Today, CEPSA announced its name change to Moeve, marking a historic milestone in the company’s transformation. This change positions Moeve as a leader in the European...

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US...

The International Platinum Group Metals Association (IPA) is calling on policymakers to urgently drive forward the deployment of fuel cell electric vehicles (FCEVs)...

Ineos Styrolution, a supplier of styrenics materials, recently confirmed it will not restart its styrene monomer production site in Sarnia, Ontario, Canada, which has...

Italian energy group Eni has finalized its transformation and relaunch plan for Versalis, its chemicals business. As part of the plan, Eni will invest about €2 billion to...